Human CellExp™ CD160, human recombinant | P1110

CD160 is a GPI-anchored lymphocyte surface receptor in which expression is mostly restricted to the highly cytotoxic CD56(dim) CD16(+) peripheral blood NK subset. CD160 is a receptor showing broad specificity for both classical and non-classical MHC class I molecules. CD160 acts as a co-activator receptor for CD3-induced proliferation of CD4+ CD160+ T cells isolated from inflammatory skin lesions. CD160-Fc fusion protein targets a novel costimulatory pathway and prolongs allograft survival.

P1110 | Human CellExp CD160 human recombinant DataSheet

Biomolecule/Target: CD160

Synonyms: Natural Killer Cell Receptor BY55, NK28, NK1

Alternates names: Placenta Growth Factor-2, PGFL

Taglines: N/A

NCBI Gene ID #: 5228

NCBI Gene Symbol: PGF

Gene Source: Human

Accession #: AAB30462

Recombinant: Yes

Source: CHO cells

Purity by SDS-PAGEs: 90%

Assay: SDS-PAGE

Purity: N/A

Assay #2: N/A

Endotoxin Level: < 0.06 EU/g

Activity (Specifications/test method): N/A

Biological activity: The PLFG-2 is fully biologically active when compared with standards. Recombinant human PIGF-2 can bind to immobilized rh-sFlt-1 (100 ng/well) with linear range at 0.3-10 ng/ml.

Results: 0.3-10 ng/ml

Binding Capacity: N/A

Unit Definition: N/A

Molecular Weight: 18.0 kDa

Concentration: N/A

Appearance: Lyophilized

Physical form description: Lyophilized from 0.2 m-filtered solution in PBS

Reconstitution Instructions: Reconstitute the protein in sterile 20 mM acetic acid to a concentration of 0.1-1.0 g/l. The solution can then be diluted into other aqueous buffer

Amino acid sequence: N/A